Viewing Study NCT06863961


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2025-12-25 @ 12:15 PM
Study NCT ID: NCT06863961
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-03-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module